Pharmacist 👩🏼‍⚕️ | Educator 👩🏼‍🏫 | Writer 📝 | Clinical Researcher 🩺 | Colorado Native 🏔 | Slow Runner 🏃🏼‍♀️| she/her | Views & posts are my own

Joined March 2009
1,480 Photos and videos
Sarah L. Anderson, PharmD (she/her) retweeted
#EndometrialCancer and #OvarianCancer treatments are evolving beyond chemo-only approaches. Drs. Sarah Hayward, Jennifer MacDonald, and @ErinHZPharmD break down evidence and share day-to-day management approaches for oncology pharmacists: bit.ly/4qZ4GGD #HOPA2026 #MedEd
2
3
104
Sarah L. Anderson, PharmD (she/her) retweeted
Join us at #EHA2026 Congress for a #CLL symposium with Priv.-Doz. Dr. med. Paula Cramer, Professor George Follows, MD, PhD, and Jennifer Woyach, MD. Explore updated targeted treatment sequencing in Stockholm on 6/13 & virtually on 6/25: bit.ly/Stockholm26-T @PeerView #HemOnc #MedEd
9
12
440
Sarah L. Anderson, PharmD (she/her) retweeted
Remember to join us Thursday, June 11, at 7:00 PM CDT, for our #LipidManagement #ASCVD live in-person symposium: bit.ly/Hyperlipidemia26-T #NLASessions
4
6
147
Coming up next Tuesday! We hope you’ll join us!
Join Dr. Eileen Scully (@EileenScully9) on June 16 at 7:00 PM EDT for an #HIV #MedEd event! Register here: bit.ly/HIVCare-T #InfectiousDisease
3
5
78
Sarah L. Anderson, PharmD (she/her) retweeted
#Neuroendocrine carcinoma (NEC) care is advancing. Learn how emerging evidence around DLL3-directed therapies and DLL3/CD3 BiTEs may help shape precision-driven treatment strategies and improve patient outcomes: bit.ly/40m8aY9 #Oncology #MedEd @Ja_Capdevila
4
7
187
Sarah L. Anderson, PharmD (she/her) retweeted
Seeking support after head and neck cancer treatment? Join the 2026 Head & Neck Cancer Survivorship Symposium on 7/18 in Boston or online. Hear from experts, gain practical insights for life after treatment, and connect with a community that understands your journey. Register: bit.ly/HNCSS26 Hosted by @hncalliance & @AHNSinfo #HeadAndNeckCancer #CancerSurvivorship
3
5
115
Sarah L. Anderson, PharmD (she/her) retweeted
💥 Statins aren't always enough. 🫀 Ready to reduce residual #ASCVD risk? Join @PeerView & Drs. @CBallantyneMD & Jessica Peña tomorrow 6/11 at 7:00 PM CDT during #NLASessions for expert-led #MedEd on personalized #LipidManagement. 🔗 bit.ly/Hyperlipidemia26-T @nationallipid
1
5
7
609
Sarah L. Anderson, PharmD (she/her) retweeted
Join Drs. Whittle & Metrock on Monday, 29 June at 12:30 PM AEST during #ISPNO2026 for an #NF1 #MedEd event: bit.ly/Sydney26-T #Oncology #NeuroOncology #Neurology
1
4
5
131
Sarah L. Anderson, PharmD (she/her) retweeted
We're excited to present new findings at #EHA2026 this Friday, 12 June, at 18:45 CEST. Our poster, “Operational Integration of T-Cell–Engaging Bispecific Antibodies in Community Hematology,” explores how educational interventions improved community clinician preparedness for integrating bispecific therapies into practice. Be sure to check out our additional publications at #EHA2026 on the role of education for improving personalized care for AML, treatment selection and sequencing in CLL, and trends in clinician preparedness for use of 1L therapy in mantle cell lymphoma. Join us at our CLL symposium, presented in partnership with @HealthTree and supported by @EliLillyandCo, on 13 June: bit.ly/Stockholm26-T #CLL #HemOnc #MedEd
6
8
284
Sarah L. Anderson, PharmD (she/her) retweeted
Remember to join us Saturday, June 13, at 9:45 AM CEST, for our #CLL in-person symposium: bit.ly/Stockholm26-T #EHA2026
4
5
103
Sarah L. Anderson, PharmD (she/her) retweeted
aHUS is a type of thrombotic microangiopathy (TMA), a group of severe and potentially life-threatening rare disorders that cause blood clots and damage to blood vessels, which can lead to organ failure and death. Learn more about TMAs ⬇️
2
2
214
Sarah L. Anderson, PharmD (she/her) retweeted
Great discussion and valuable insights from Drs. Goldman, Camidge (@DRCamidge), and Le (@LeXiuning) during #ASCO26 on Saturday! 📺 Watch the replay on demand: bit.ly/2026METLung-T Thanks to @AbbVie for support and @LUNGevity for collaboration. #CME #Oncology #MedEd
5
9
184
Sarah L. Anderson, PharmD (she/her) retweeted
#CART therapy is transforming #lymphoma care! Pharmacists play a critical role in education, care coordination, safety management, and post-treatment monitoring throughout the CAR-T journey. Watch this #MedEd activity today to learn more: bit.ly/4qLGdV3
2
3
87
Sarah L. Anderson, PharmD (she/her) retweeted
Appreciation to @LealTiciana, @BenCreelan, and @JuliaRotow for a thoughtful and impactful session at #ASCO26 on Saturday! Replay available here: bit.ly/2026immunoLung-T Thank you to @AstraZeneca, @Regeneron, and @SMMT_TX for grant support & @LUNGevity for collaboration. #CME #MedEd
4
8
215
Sarah L. Anderson, PharmD (she/her) retweeted
Great discussion and valuable insights from Drs. Leighl, Jänne and Sabari (@JSabari) during #ASCO26 on Saturday! 📺 Watch the replay on demand: bit.ly/2026EGFRLung-T Thanks to @AstraZeneca, @JNJNews, and Black Diamond Therapeutics for support & @LUNGevity for collaboration. #CME #Oncology #MedEd
3
6
213
Sarah L. Anderson, PharmD (she/her) retweeted
Thank you to Drs. Tawbi (@HTawbi_MD), Gibney, and McKean (@MeredithMcKean) for an engaging discussion at #ASCO26 on Saturday! 📺 Missed it? Watch the replay: bit.ly/2026Melanoma-T Appreciation to @bmsnews & @Merck for grant support #CME #MedEd
4
9
257
Sarah L. Anderson, PharmD (she/her) retweeted
Join Drs. Cramer, Follows, and Woyach on 6/13 at 9:45 AM CEST during #EHA2026 for a #CLL #MedEd event. Produced with @HealthTree. bit.ly/Stockholm26-T #HemOnc
5
6
200